• English
    X

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    Maryland Department of Health
    Newsroom

    ​
    October 28, 2020

    Media Contact:

    Deidre McCabe, Director, Office of Communications, 410-767-3536

    Charles Gischlar, Deputy Director, Office of Communications, 410-767-6491

     

    Maryland Department of Health awards more than $50 million in new grant funding to combat opioid crisis in local communities

     

    Baltimore, MD – The Maryland Department of Health (MDH) today announced awards for more than $50 million in new grant funding to advance substance use disorder treatment, prevention and recovery support initiatives in communities statewide through the State Opioid Response (SOR) II grant. Made possible by the Substance Abuse and Mental Health Services Administration, SOR II includes more than $12 million in funding for new grant recipients. 

     

    “As we see opioid and other substance use-related deaths on the rise again in Maryland, we need to once again meet this crisis head on,” said MDH Secretary Robert R. Neall. “This funding will help ensure access to local, life-saving, evidence-based treatment and programs that will help more Marylanders get onto the path to recovery.”

     

    SOR II funding is effective through Sept. 29, 2022 and extends SOR I objectives by addressing stimulant use disorders — including cocaine and methamphetamines – in addition to opioid use disorders. SOR II funding will also help support new initiatives including:

     

    ●      Crisis stabilization for young adults and adolescents with opioid use disorder

    ●      Training and capacity building through Historically Black Colleges and Universities and other higher education institutions to support students enrolled in behavioral health-related programs

    ●      Initiatives for Native Americans and tribes to provide culturally relevant and evidence-based community prevention efforts

    ●      Expanded residential substance use treatment programs for women with children         

    ●      Developing a centralized crisis call center for 24/7 opioid and mental health crises

    ●      Baltimore City opioid treatment pilot program to improve medication adherence and safety using a smart pill electronic dispenser

     

    “In light of COVID-19 and the new challenges imposed upon all of us, these funds are coming at a critical time,” said MDH Behavioral Health Administration Deputy Secretary Dr. Aliya Jones. “Now is the time to concentrate on bringing proven treatments to more people.''


    New SOR II grant allocations include:

     

    ●      Adolescent and young adult services expansion: $7,984,229

    ●      Historically Black Colleges and Universities workforce initiative: $1,045,400

    ●      Substance Use Disorder Workforce Expansion Fellowship: $1,061,863

    ●      Evidence-based initiatives to Native Americans and tribes: $500,000

    ●      Expansion of residential substance abuse treatment for women with children: $240,935

    ●      Centralized crisis call center (211): $1,132,400

    ●      Harford County crisis hotline: $327,500

    ●      Medication adherence technology including video and an electronic pill dispenser for take-home methadone (Baltimore City): $326,896

    ●      Bridge medication-assisted treatment (MAT) program (Kent County): $110,454

     

    Maryland’s SOR I grant supported 27 initiatives from Sept. 30, 2018 to Sept. 29, 2020, including harm reduction, public awareness, crisis beds, 24/7 crisis walk-in stabilization centers, MAT in detention centers, safe stations, adult recovery residences and two recovery support services programs. The initiatives span 158 programs within all Maryland jurisdictions. Services provided through Aug. 31 include:

     

    ●      48,636 individuals trained in the use of the overdose reversal drug naloxone

    ●      112,609 doses of naloxone distributed

    ●      62,203 individuals served in the areas of prevention, treatment and recovery

    ●      315,402 individuals screened using the Screening, Brief Intervention and Referral to Treatment model

    ●      2,537 individuals started MAT

    ●      2,970 individuals referred to MAT

    ●      1,872 individuals referred to outpatient substance use disorder treatment

    ●      5,277 individuals referred to American Society of Addiction Medicine substance use disorder residential treatment services

     

    For more information about SOR II grants, visit https://www.samhsa.gov/newsroom/press-announcements/202008270530​.

     

    To view Maryland substance use overdose and mortality reports, visit https://health.maryland.gov/vsa/Pages/overdose.aspx.


    ###

     

    The Maryland Department of Health is dedicated to protecting and improving the health and safety of all Marylanders through disease prevention, access to care, quality management and community engagement.

     

    Follow us at http://www.twitter.com/MDHealthDept and https://www.facebook.com/MDHealthDept.​